2,5-Dimethoxy-4-nitroamphetamine

2,5-Dimethoxy-4-nitroamphetamine (DOx series), also known as Aleph-7, is a psychedelic drug and a member of the amphetamine family. It is one of the most potent compounds in the DOx series, known for its hallucinogenic and psychedelic effects.

Chemistry

2,5-Dimethoxy-4-nitroamphetamine is a synthetic molecule of the amphetamine class. Molecules of this class contain a phenethylamine core featuring a phenyl ring bound to an amino (NH2) group through an ethyl chain with an additional methyl substitution at Rα.

Pharmacology

The mechanism that produces the hallucinogenic and entheogenic effects of 2,5-Dimethoxy-4-nitroamphetamine is thought to result primarily from 5-HT2A receptor agonism. However, the role of these interactions and how they result in the psychedelic experience continues to remain elusive.

Effects

The effects of 2,5-Dimethoxy-4-nitroamphetamine are similar to other drugs in the DOx series and include open and closed eye visuals, time distortion, enhanced introspection, and euphoria.

Risks

As with all psychedelics, there are several physical and psychological risks associated with the use of 2,5-Dimethoxy-4-nitroamphetamine. These include potential for overstimulation, panic attacks, and psychosis in those predisposed.

Legality

2,5-Dimethoxy-4-nitroamphetamine is a Schedule I controlled substance in the United States, meaning it is illegal to manufacture, buy, possess, or distribute without a DEA license.

See also

• DOx
• Psychedelic drug
• Amphetamine

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian